If you made any changes in Pure these will be visible here soon.

Research Output

2020

Multicenter Single-Arm, Two-Stage Phase 2 Study of Panitumumab in Patients With Cetuximab-Refractory Metastatic Colorectal Cancer: The PACER Trial

Piccirillo, M. C., Avallone, A., Carlomagno, C., Maiello, E., Rosati, G., Alabiso, O., Nasti, G., De Placido, S., Latiano, T. P., Bilancia, D., Ottaiano, A., De Stefano, A., Romano, C., Silvestro, L., Nappi, A., Cassata, A., Giordano, P., Iaffaioli, R. V., Normanno, N., Perrone, F. & 1 others, Daniele, B., 2020, (Accepted/In press) In : Clinical Colorectal Cancer.

Research output: Contribution to journalArticle

Study of ras mutations’ prognostic value in metastatic colorectal cancer: Storia analysis

Ottaiano, A., Normanno, N., Facchini, S., Cassata, A., Nappi, A., Romano, C., Silvestro, L., De Stefano, A., Rachiglio, A. M., Roma, C., Maiello, M. R., Scala, S., Delrio, P., Tatangelo, F., Di Mauro, A., Botti, G., Avallone, A. & Nasti, G., Jul 2020, In : Cancers. 12, 7, p. 1-14 14 p., 1919.

Research output: Contribution to journalArticle

Open Access
2019
Open Access
2018

Biotherapies in solid tumors: Are negative results still of low priority for publication?

Ottaiano, A., Cassata, A., Capozzi, M., De Divitiis, C., De Stefano, A. & Avallone, A., Mar 14 2018, In : Frontiers in Oncology. 8, MAR, 62.

Research output: Contribution to journalArticle

First biologic drug in the treatment of RAS wild-type metastatic colorectal cancer: Anti-EGFR or Bevacizumab? Results from a meta-analysis

Ottaiano, A., De Stefano, A., Capozzi, M., Nappi, A., De Divitiis, C., Romano, C., Silvestro, L., Cassata, A., Casaretti, R., Tafuto, S., Caraglia, M., Berretta, M., Nasti, G. & Avallone, A., May 3 2018, In : Frontiers in Pharmacology. 9, MAY, 441.

Research output: Contribution to journalReview article

Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: A real practice study with long-term outcome and prognostic factors

Ottaiano, A., Scotti, V., De Divitiis, C., Capozzi, M., Romano, C., Cassata, A., Casaretti, R., Silvestro, L., Nappi, A., Vicario, V., De Stefano, A., Tafuto, S., Berretta, M., Nasti, G. & Avallone, A., Oct 1 2018, In : Oncotarget. 9, 81, p. 35251-35265 15 p.

Research output: Contribution to journalArticle

Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC

Pinto, C., Normanno, N., Orlandi, A., Fenizia, F., Damato, A., Maiello, E., Tamburini, E., Di Costanzo, F., Tonini, G., Bilancia, D., Corsi, D., Pisconti, S., Ferrau, F., Gori, S., Daniele, B., Zaniboni, A., Soto Parra, H., Frassinetti, G. L., Iaffaioli, R. V., Cassata, A. & 4 others, Zampino, M. G., Repetto, L., Calegari, M. A. & Barone, C., 2018, In : Future Oncology. 14, 14, p. 1339-1346 8 p.

Research output: Contribution to journalArticle

Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC

Pinto, C., Normanno, N., Orlandi, A., Fenizia, F., Damato, A., Maiello, E., Tamburini, E., Di Costanzo, F., Tonini, G., Bilancia, D., Corsi, D., Pisconti, S., Ferrau, F., Gori, S., Daniele, B., Zaniboni, A., Soto Parra, H., Frassinetti, G. L., Iaffaioli, R. V., Cassata, A. & 4 others, Zampino, M. G., Repetto, L., Calegari, M. A. & Barone, C., 2018, In : Future Oncology. 14, 14, p. 1339-1346 8 p.

Research output: Contribution to journalArticle

Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC

Pinto, C., Normanno, N., Orlandi, A., Fenizia, F., Damato, A., Maiello, E., Tamburini, E., Di Costanzo, F., Tonini, G., Bilancia, D., Corsi, D., Pisconti, S., Ferrau, F., Gori, S., Daniele, B., Zaniboni, A., Soto Parra, H., Frassineti, G. L. P., Iaffaioli, R. V., Cassata, A. & 4 others, Zampino, M. G., Repetto, L., Calegari, M. A. & Barone, C., 2018, In : Future Oncology. 14, 14, p. 1339-1346 8 p.

Research output: Contribution to journalArticle

2017

FOLFOXIRI in metastatic colorectal cancer: A criticism from its native land

Ottaiano, A., Nasti, G., Cassata, A., De Stefano, A., Caraglia, M. & Avallone, A., Nov 1 2017, In : Cancer Letters. 408, p. 71-72 2 p.

Research output: Contribution to journalShort survey

2016

Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy

Ottaiano, A., Nappi, A., Tafuto, S., Nasti, G., De Divitiis, C., Romano, C., Cassata, A., Casaretti, R., Silvestro, L., Avallone, A., Capuozzo, M., Capozzi, M., Maiolino, P., Quagliariello, V., Scala, S. & Iaffaioli, V. R., Jan 1 2016, In : Oncology. 90, 1, p. 36-42 7 p.

Research output: Contribution to journalArticle

2015

Tardiva risposta completa dopo lunga remissione da trattamento con schedula FOLFIRI-aflibercept per cancro colorettale metastatico dopo progressione a schedula folfox-bevacizumab

Translated title of the contribution: Late complete response after long remission from treatment with FOLFIRI-aflibercept for metastatic colorectal cancer after progression to FOLFOX-bevacizumabDe Divitiis, C., Cassata, A., Nasti, G., Ottaiano, A., Nappi, A., Barretta, M. L. & Iaffaioli, R. V., Aug 1 2015, In : Recenti Progressi in Medicina. 106, 8, p. e407-e413

Research output: Contribution to journalArticle

2013
2012
2010
2004

Randomized Multicenter Phase II Trial of Two Different Schedules of Irinotecan Combined with Capecitabine as First-Line Treatment in Metastatic Colorectal Carcinoma

Bajetta, E., Di Bartolomeo, M., Mariani, L., Cassata, A., Artale, S., Frustaci, S., Pinotti, G., Bonetti, A., Carreca, I., Biasco, G., Bonaglia, L., Marini, G., Iannelli, A., Cortinovis, D., Ferrario, E., Beretta, E., Lambiase, A. & Buzzoni, R., Jan 15 2004, In : Cancer. 100, 2, p. 279-287 9 p.

Research output: Contribution to journalArticle

2001

Capecitabine: Indications and future perspectives in the treatment of metastatic colorectal and breast cancer

Cassata, A., Procopio, G., Alù, M., Ferrari, L., Ferrario, E., Beretta, E., Longarini, R., Busto, G., De Candis, D. & Bajetta, E., 2001, In : Tumori. 87, 6, p. 364-371 8 p.

Research output: Contribution to journalArticle

Nuovi farmaci nella terapia del carcinoma colorettale

Translated title of the contribution: New drugs in the treatment of colorectal carcinomaBajetta, E., Cassata, A. & Cortinovis, D., 2001, In : Tumori. 87, 1 SUPPL. 1

Research output: Contribution to journalArticle

1999

Fluoropyrimidines in the treatment of advanced neoplastic diseases: Role and advantages of UFT

Del Vecchio, M., Procopio, G., Cassata, A., Pozzi, P., Busto, G., Celio, L. & Bajetta, E., Jan 1999, In : Tumori. 85, 1, p. 6-11 6 p.

Research output: Contribution to journalArticle

1998

5-fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors

Bajetta, E., Rimassa, L., Carnaghi, C., Seregni, E., Ferrari, L., Di Bartolomeo, M., Regalia, E., Cassata, A., Procopio, G. & Mariani, L., Jul 15 1998, In : Cancer. 83, 2, p. 372-378 7 p.

Research output: Contribution to journalArticle

Oral doxifluridine plus levoleucovorin in elderly patients with advanced breast cancer

Bajetta, E., Biganzoli, L., Carnaghi, C., Di Bartolomeo, M., Spagnoli, I., Cassata, A., Galante, E., Mariani, L., Stampino, C. G. & Buzzoni, R., Sep 15 1998, In : Cancer. 83, 6, p. 1136-1141 6 p.

Research output: Contribution to journalArticle